Supporting usage for a launch product
This case study covers a 19-month clinical messaging campaign in the UK for "Product Z," a newly launched bi-annual injectable cholesterol-lowering drug. The campaign aimed to encourage prescribing and support usage of the newly launched medication. The page states the initiative achieved "an 89% increase in prescription of Product Z during the campaign."
The customer is anonymised in Clarivate’s own case study — not withheld by us.
Clarivate owns Cortellis, the curated competitive-intelligence and pipeline-tracking platform standard in pharma portfolio-management teams.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Clarivate on its own site — read the original case study on clarivate.com ↗
Related use cases
- 01How Bioventus evolved their commercial strategy with real world data and intelligence
- 02Clarivate and CLEO diagnostics are making early detection of ovarian cancer a reality
- 03Making informed investment decisions (Attracting breakthrough innovations from academic research) - SPRIND case study
- 04Gedeon Richter — Case study | Clarivate Regulatory Intelligence Tracking Application
- 05Integrating patient centricity into the Menarini mature brand strategy for commercial excellence
- 06Artificial Intelligence in Pharmacovigilance: Using AI to help GSK detect ICSRs in scientific literature